Newsfeeds - Spark Newswire

1 minute read

FDA
News

Trevi Therapeutics Announces Clinical Trial Updates For Lead Indications

Today, 2:45 PM

Phase 2 CANAL (Chronic Cough in IPF) Planned Interim Statistical Update 1Q 2022, with Top-Line Data 1H 2022 Phase 2b/3 PRISM (Chronic Pruritus in PN) Enrollment to End January 31, 2022, with Top-Line Data 1H

TRVI

18 minute read

Earnings Scheduled For November 10, 2021

By Benzinga Insights

Today, 2:45 PM

Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.

AACG

2 minute read

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 2:45 PM

AWH

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 2:45 PM

Gainers

ENZ

1 minute read

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

Today, 2:45 PM

Gainers Viridian Therapeutics (NASDAQ:VRDN) stock rose 22.49% to $19.17 during Tuesday's pre-market session. The company's market cap stands at $331.8 million.

DYNT

3 minute read

46 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:45 PM

Gainers

ACY

2 minute read

28 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 2:45 PM

Gainers

ACY

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 2:45 PM

Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares moved upwards by 89.3% to $34.53 during Monday's pre-market session. The market value of their outstanding shares is at $1.6 billion.

ADMS